Thermo Fisher Scientific Inc. closed 32.13% below its 52-week high of $627.88, which the company achieved on September 10th.

Thermo Fisher did not immediately respond to a Reuters' request for comment. In February, the company acquired Solventum's purification and filtration business for about $4.1 billion in cash.

In my opinion, Thermo Fisher has been successful in investing significant financial resources to expand its operations. See why I grant TMO stock a Buy rating.

Thermo Fisher's 2025 headwinds from tariffs and US research funding cuts are real but temporary. Read why TMO stock is a Strong Buy.

Mirai Bio and Thermo Fisher partner to integrate AI-driven design with CGMP manufacturing, aiming to streamline development of genetic medicines.

(RTTNews) - Thermo Fisher Scientific Inc. (TMO) announced Thursday its plan to invest an additional $2 billion in the United States over the next four years to boost manufacturing capacity.

Thermo Fisher cut its 2025 EPS and revenue outlook due to tariffs and U.S. policy changes, expecting a $400 million sales hit and lower operating income.

Key Takeaways Thermo Fisher’s Q1 2025 EPS of $5.15 exceeded forecasts. Revenue for the quarter was $10.36 billion, slightly above expectations. Stock price surged by 4.25% post-earnings ...

Thermo Fisher (TMO) delivered earnings and revenue surprises of 0.98% and 1.11%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Thermo Fisher Scientific CIO Ryan Snyder believes business strategy and tech strategy should be woven together and that data should be co-owned across the company.

Key Takeaways Shares of Solventum rose Tuesday after the company agreed to sell its filtration and purification business to medical device maker Thermo Fisher Scientific for $4.1 billion.

Thermo Fisher Scientific is growing its lab equipment empire with a deal to buy 3M’s former purification and filtration business for $4.1 billion.